Figure 4.

Enriched tumor specific proteins and associated biological pathways between the NOS and SRC subgroups and potential targets

(A) The Kaplan-Meier curve shows the difference in patient survival between patients in NOS and the rest of patients from the SRC histological subtype. The log rank test was used to calculate the p value.

(B) Volcano plot shows the DEPs between two NOS and SRC with a tumor-immune of log2(fold change) > 1 and p value <0.05, different colors indicate the significant genes involving in oncogenic (black), cell cycle (light blue), metabolic (orange) and immune response (pink) pathways.

(C) The pathway enrichment analysis identified biological pathways enriched in the SRC subtype. Pathways are colored by their biological functions.

(D) The pathway enrichment analysis identified biological pathways enriched in the NOS subtype. Pathways are colored by their biological functions.